The SPPB is an assessment of physical limitations. It combines scores from a balance test, gait speed test, and a chair stand test. The total possible range of scores is 1-12, higher scores indicate better function/less functional limitations.
Baseline
Group
Value
95% CI
Stand up Intervention
8.05
± 2.46
Control
7.65
± 2.60
4 weeks
Group
Value
95% CI
Stand up Intervention
9.29
± 2.65
Control
7.44
± 2.31
12 weeks
Group
Value
95% CI
Stand up Intervention
10.45
± 2.01
Control
8.00
± 2.81
Sponsor's own description
The purpose of the expanded study is to examine the effectiveness of a "Stand Up and Move More" intervention to reduce sedentary behavior in older adults from underserved communities.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Wisconsin, Madison
Last refreshed: 16 December 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03412084.